ValGenesis, Inc., the global leader in digital validation lifecycle management and creator of the industry's first AI-native validation platform, ValGenesis Smart GxP™, today announced the appointment of Wayne Baker as chief revenue officer. In this role, Baker will lead the company's global revenue organization, overseeing sales strategy, customer expansion, partner-led growth, and commercial execution across key markets. Baker joins ValGenesis at a pivotal stage in the company's growth as life sciences organizations accelerate their shift from manual, document-heavy validation processes.
Wayne Baker appointed Chief Revenue Officer at ValGenesis.
25+ years in technology, life sciences, and commercial leadership.
Previously Chief Commercial Officer at Greenphire.
Earlier Chief Sales Officer at Advanced Health Media (AHM).
ValGenesis Smart GxP unifies validation and process lifecycle management.
VAL brings governed AI into validation workflows.
Dr. Siva Samy, founder and CEO of ValGenesis, stated: "Wayne is joining ValGenesis at one of the most exciting moments in our company's history. The life sciences industry is at an inflection point. Customers are no longer looking only to digitize validation. They want to use AI to transform how validation, process development, tech transfer, manufacturing, and continued process verification are connected across the product lifecycle. Wayne's deep experience in life sciences technology, commercial strategy, and enterprise growth makes him the ideal leader to help us accelerate this next phase."
Baker brings more than 25 years of experience in technology, life sciences, and commercial leadership. Most recently, he served as a strategic growth executive and adviser to select life sciences solution providers. Previously, Baker was chief commercial officer at Greenphire, where he helped scale one of the industry's leading clinical technology companies. Earlier, he served as chief sales officer at Advanced Health Media (AHM).
Wayne Baker stated: "ValGenesis has created a unique opportunity to redefine how life sciences companies approach validation and product lifecycle digitalization. The combination of Smart GxP, VAL, and the company's deep domain expertise gives customers a powerful way to improve compliance, reduce cycle times, and bring critical therapies to market faster. I'm excited to partner with Siva and the entire ValGenesis team to scale the business globally and help customers realize the full value of the ValGenesis platform."
ValGenesis Smart GxP unifies validation and process lifecycle management across development, commissioning, qualification, validation (CQV), cleaning validation, operations, and continued process verification. With VAL, ValGenesis brings governed AI into validation workflows, helping teams accelerate document generation, gap assessment, execution review, anomaly detection, and compliance readiness while maintaining human oversight, traceability, and control.
About ValGenesis
ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ Platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones, and thrive on the tech pulse.
